Protein Therapy Market PowerPoint PPT Presentations

Protein Engineering Market - Significant Growth Prospects, Protein Therapy and Top-Selling Biologics Drugs Going Off–Patent in the Near Future - Copy

The "Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design), Product (Instrument, Services), Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone), End User (Academics Institutes, CROs) - Global Forecast to 2020", report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Protein Engineering market along with the estimates and forecasts of the revenue and market share analysis.

Read here the latest updates on the Cell Surface Markers Market published by CMI team.

Read here the latest updates on the Hemophilia gene therapy market analysis published by the CMI team.

Big Market Research “Protein Engineering Market by Technology” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.prnewswire.com/news-releases/protein-engineering-market-would-grow-at-157--cagr-amid-the-period-2015-2020-521544791.html Protein Engineering Market by Technology (Rational Protein Design, Irrational Protein Design) , Product (Instrument, Services) , Protein Type (Monoclonal Antibodies, Interferon, Growth Hormone) Global Forecast to 2020 - Developing Asian countries such as the China and India are lucrative markets for protein engineering, owing to increase in R&D investment by the biologics companies in these regions.

The global Jet Lag Therapy Market will be worth USD 548.5 million by 2027, according to a current analysis by Emergen Research. Jet lag symptoms cause a wide variety of considerable health hazards to athletes, business executives and seasonal travelers, affecting a wide range of people which is around 1 billion annually.

Furthermore, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and approximately 70% of deaths from cancer occur in low- and middle-income countries. By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths is expected to rise to 16.4 million. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market required for drug efficacy and safety.

Global phage therapy market is expected to foresee a compound annual growth rate of 8.1% from 2021 to 2028. The major factors driving the growth of the phage therapy market are antibiotics resistance, the increased prevalence of food-borne diseases, use of phage therapy in the food & beverage industry, application of bacteriophage specific to target bacteria, extensive research & development, and increasing antimicrobial resistance. Nowadays antibiotics resistance has become one of the biggest threats to global health as it can affect people of any age group.

Protein Therapeutics Market, By Therapeutic Proteins (Monoclonal Antobodies (mAbs), Erythropoietin (EPO), Insulin, Interferon (IFN), Human Growth Hormone (HGH), Follicle Stimulating Hormone (FSH), Blood Clotting Factors) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

The growing investments in the synthetic biology sector and the increasing focus towards protein-based drug development are among the primary factors driving the protein engineering market. In line with this, the shifting preferences among consumers from non-protein drugs to protein therapeutics, owing to the associated positive clinical outcomes, are further propelling the market growth.

PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis report is an essential source of information and analysis on the gene therapy field. See Full Report: http://goo.gl/lU376R

Gene Therapy Market is likely to witness an impressive CAGR of 27.8% during the forecast period. The prime factors contributing to the growth of the market are rising incidences of cancer, and other chronic diseases, availability of reimbursements, and increasing approvals and launches of new products.

Factor VIII is a vital blood-clotting protein, which is also known as an antihemophilic factor. In individuals, the factor VIII is mainly encoded by the F8 gene. The defects in this gene lead to haemophilia A, which is a recessive X-linked coagulation disorder. Factor VIII has been generated in liver sinusoidal cells and endothelial cells outside the liver around the body.

Transient Protein Expression market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transient Protein Expression market will be able to gain the upper hand as they use the report as a powerful resource.

Global Organic Pea Protein Market is expected to rise from its initial estimated value of USD 13.12 billion in 2018 to an estimated value of USD 32.76 billion by 2026

Global Organic Pea Protein Market is expected to rise from its initial estimated value of USD 13.12 billion in 2018 to an estimated value of USD 32.76 billion by 2026

Global Organic Pea Protein Market is expected to rise from its initial estimated value of USD 13.12 billion in 2018 to an estimated value of USD 32.76 billion by 2026, registering a CAGR of 12.12%

Global Organic Pea Protein Market is expected to rise from its initial estimated value of USD 13.12 billion in 2018 to an estimated value of USD 32.76 billion by 2026, registering a CAGR of 12.12% in the forecast period of 2019-2026.

Latest research report “Therapeutic Protein Market” published by TBRC provides Market Analysis Forecast, Size, Trends, Key Players, Segments and Growth. Read Full Report: http://bit.ly/2MJL7mr Request a Sample: http://bit.ly/2UiFhsQ

Batten disease is known to be a rare, inherent, and fatal nervous system disorder. It is the most general form of a group of disorders named as the neuronal ceroid lipofuscinoses (NCLs), which is known to be a class of life-limiting genetic neurogenerative diseases that are triggered because of abnormality of genes resulting in their inability to synthesize the essential protein. https://www.databridgemarketresearch.com/reports/global-batten-disease-treatment-market

Zoonotic Disease Treatment Market report segmented the market by disease types & geography with in-depth analysis on revenue, trends, growth, share, size & forecast to 2022

Antibody Production Market research report on global market revenue, trends, growth, share, size and forecast to 2022.

Technavios market research analyst predicts the global protein therapeutics market to grow steadily at a CAGR of 8% during the forecast period. Increased demand for and use of monoclonal antibodies is expected to drive the growth of the protein therapeutics market as it accounts for more than half of the protein therapeutics market.

CAR T Cell Therapy Market

Looking forward, the whey protein market value is projected to reach a strong growth during the forecast period (2021-2026).

Looking forward, the fish protein hydrolysate market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/fish-protein-hydrolysate-market

Bharat Book Bureau provides the report on “Antibacterial Therapies Drug Market”, (https://www.bharatbook.com/healthcare-market-research-reports-842536/antibacterial-therapies-drug-development.html) The report includes an analysis of products by stage of development, molecular target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Global plasma therapy market is registering a healthy CAGR of 15.7% in the forecast period of 2019-2026. This rise in the market value can be attributed to the growth in the use of planet rich plasma for the treatment of various diseases that drives the growth of the industry and increasing incidents of sports injuries.

Global plasma therapy market is registering a healthy CAGR of 15.7% in the forecast period of 2019-2026. This rise in the market value can be attributed to the growth in the use of planet rich plasma for the treatment of various diseases that drives the growth of the industry and increasing incidents of sports injuries.

Looking forward, the cell culture protein surface coating market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/cell-culture-protein-surface-coating-market

Looking forward, the virus filtration market value is projected to reach a strong growth during the forecast period (2022-2027). More info:- https://www.imarcgroup.com/virus-filtration-market

Genetic disorders market is forecast to grow from $19.6 billion in 2016 to $47.7 billion in 2023, at a CAGR of 13.6%. This high level of growth will be driven largely by orphan drugs for the treatment of rare genetic disorders. Report titled “Global Genetic Disorders Drugs Market to 2023 - A Rapidly Growing Treatment Landscape Driven by Targeted Complement System Inhibitors and Enzyme Replacement Therapies to Treat PNH and Lysosomal Storage Disease” helps the reader to gain more insights in the area of genetic disorders covering aspects such as Symptoms, Diagnosis, Treatment, Key products, clinical trials, company analysis and future forecast. To know more about the publication, click https://www.kenresearch.com/contact-us.php

Molecular Diagnostics Market - Technologies [PCR, DNA Sequencing, Microarray, Transcription Mediated Amplification, Hybridization], Applications Virology/Infectious Diseases, Cancer/ Oncology, Genetic Testing, Blood Screening, Microbiology] Global Opportunities, Competitor Analysis & Forecasts to 2017

Organic Pea Protein Market get sample copy visit us on website

The Cardiovascular Disease (CVD) therapy area encompasses a range of different diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dyslipidemia, which accelerate the development of atherosclerotic plaque build up within blood vessels. For more information on the research report, refer to below link:- https://www.kenresearch.com/healthcare/pharmaceuticals/global-cardiovascular-disease-drugs-market-to-2023/142623-91.html

Complete report on Thalassemia market spread across 45 pages providing 4 company profiles and 4 tables and 28 charts is now available at http://www.marketreportsonline.com/478060.html.

The global advanced medicinal therapy products are segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global advanced medicinal therapy products market, owing to the development in the field of cell and gene therapy.

Global Biological Drugs Market is estimated to reach $394 billion by 2024; growing at a CAGR of 10.3% from 2016 to 2024. Biological drugs are complex molecules manufactured by using living plant or animal cells or micro-organisms.

Get sample Brocure Now @ http://tinyurl.com/h2sgua6 Gene therapies have been in development in humans for 25 years, and a number of products have begun to enter the pharmaceutical market. However, due to various challenges and clinical trial setbacks, progress in developing this technology and achieving suitability for commercial usage has been slow. However, the pipeline is robust; 906 pipeline gene therapies are currently in development. Most are at an early stage of development, with 76% at the Discovery or Preclinical stage. However, there are currently 23 gene therapy programs in Phase III development and two at the Pre-registration stage.

The global whey protein (powder and concentrate) market has witnessed a steady growth in recent years. The major factors which have helped in driving the market growth are its applications in various industries, nutritional properties and health benefits. To get more information about the market, please visit @ http://www.imarcgroup.com/wheat-starch-processing-plant Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: http://www.imarcgroup.com Follow us on twitter : @imarcglobal

MarketReportsOnline.com adds "Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market: Size, Trends and Forecast (2016-2020)" report to its research store. The report titled “Global Alpha 1-Antitrypsin (AAT) Replacement Therapy Market: Size, Trends and Forecast (2016-2020)” provides an in-depth analysis of the global AAT Replacement Therapy market with detailed analysis of market sizing, growth and market share. The report provides market size by value and volume along with the supply trend prevailing in the market. Purchase a copy of this research report at http://www.marketreportsonline.com/contacts/purchase.php?name=555500.

Healthcare practitioners prefer protein drugs owing to their versatility compared to non-protein drugs.

Get more information about the market: http://bit.ly/2pLf6gh The global protein ingredients market reached a value of US$ 31 Billion in 2017. Proteins are large molecules of amino acids which supports in building and repairing of tissues. As proteins help in improving the overall functioning of the body, they are regarded as the building blocks of life. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=857&flag=B Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: https://www.imarcgroup.com Follow us on twitter : @imarcglobal

Get more information about the market : http://www.imarcgroup.com/protein-ingredients-market Protein ingredients are consumed to maintain the level of proteins in a human body as they are the best source to keep the body fit.According to IMARC Group’s latest report, titled “Protein Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, the global protein ingredients market reached a value of more than US$ 41 Billion in 2016. Request a sample report: http://www.imarcgroup.com/request?type=report&id=857&flag=B Browse more reports on Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Follow us on twitter: @imarcglobal

Want more information about this market: https://www.imarcgroup.com/whey-protein-powder-and-concentrate-market IMARC’s latest study “Whey Protein (Powder and Concentrate) Market - Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” provides a techno-commercial roadmap for setting up a whey protein (powder and concentrate) manufacturing plant. Request a free report sample: https://www.imarcgroup.com/request?type=report&id=717&flag=B Browse more reports on Food & Beverages Industry: https://www.imarcgroup.com/categories/food-beverages-market-reports contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com

The global whey protein (powder and concentrate) market has witnessed a steady growth in recent years. The major factors which have helped in driving the market growth are its applications in various industries, nutritional properties and health benefits. According to IMARC Group, the global whey protein market reached a volume of around 3 Million Tons in 2016. Get more information on whey protein market @ http://www.imarcgroup.com/whey-protein-powder-and-concentrate-market Request for sample report @ http://www.imarcgroup.com/whey-protein-powder-and-concentrate-market Browse more reports on food & beverage industry @ http://www.imarcgroup.com/categories/food-beverages-market-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: http://www.imarcgroup.com Follow us on twitter : @imarcglobal

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands and feet, which hinders patient mobility. Without treatment, the disease leads to joint destruction and disability. Prior to 1998, treatment options were limited to small-molecule disease-modifying therapies, such as Methotrexate (MTX), sulfasalazine and anti-malarials. However, while MTX is efficacious in controlling RA symptoms in a large percentage of patients, approximately 33% are unresponsive to these first-line drugs. Read more details at: http://www.bigmarketresearch.com/rheumatoid-arthritis-to-2020-a-crowded-characterized-by-modest-growth-market

Get more information about the market: https://goo.gl/PU3fhG The Indian flavoured and frozen yogurt market reached a value of INR XX Billion in 2017, registering a CAGR of around 27% during 2010-2017. Frozen yogurt refers to a mixture of yogurt, milk and cream which is enjoyed as a snack or dessert by people of all ages. Some of the common frozen yogurt flavours include strawberry, banana, vanilla, blueberry, honey and mango. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/request?type=report&id=775&flag=B Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: https://www.imarcgroup.com Follow us on twitter: @imarcglobal

Graphical Research has reported the addition of the “Bioreactors Market: Europe Industry Analysis and Opportunity Assessment 2019 - 2025" report to their offering.

The report on Biological Drugs Market by Infinium Global Research analyzes the Biological Drugs Market over the period of 2017 to 2023. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Biological Drugs Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Biological Drugs Market.

CAR-T Cell Therapy Market (53% CAGR) 2017 to 2025: Global Industry Size, Share, Growth, Trends and Forecast

The report on Biological Drugs Market by roduct Type (therapeutic protein -levemir, neulasta, eylea, novolog, enbrel, avonex, neupogen, humalog, victoza, lantus, epogen, aranesp; monoclonal antibody - avastin, humira, remicade; vaccine - gardasil, prenvar 13, fluzone) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Biological Drugs Market is projected to grow at a CAGR between 10.0% to 10.5% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The report on Immunotherapy Drugs Market by product (monoclonal antibodies, checkpoint inhibitors, vaccines, inferon’s and others), by disease condition (cancer, infectious disease, autoimmune disease, and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Immunotherapy Drugs Market is projected to grow at a CAGR between 13.5 % to 14.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The report on Metabolic Disorders Therapeutics Market by disease type (diabetes, obesity, hypercholesterolemia and lysosomal storage disease), product (metachromatic leukodystrophy, globoid leukodystrophy, hepatic encephalopathy and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Metabolic Disorders Therapeutics Market is projected to grow at a CAGR of 5.7% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

This report covers the present scenario and the growth prospects of the Global Orthopedic Biomaterials market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following seven products: • Bone allografts • Machined bones • Demineralized Bone Matrix (DBM) • Bone Morphogenetic Protein (BMP) • Viscosupplementation • Stem cell therapy • Synthetic bone substitute Read more details at: http://www.bigmarketresearch.com/global-orthopedic-biomaterials-2014-2018-market

The European orthopedic biomaterials market includes bone graft substitutes (BGS), hyaluronic acid (HA) viscosupplementation, bone morphogenetic protein (BMP) growth factor therapy and autologous chondrocyte implantation (ACI). As the market continued to recover from the economic crisis, slow growth was often seen across different regions. The ACI market underwent drastic changes in 2012 due to modifications in the European Medicines Agency (EMA) regulations.